A woman in Florida became one of the latest this month to make power morcellator lawsuit allegations that a surgery tool used to aid in laparoscopic hysterectomy and fibroid removal procedures caused her uterine cancer to spread, according to court documents.

Included in her complaint, which was filed May 7th in the U.S. District Court, Southern District of Florida, are allegations that a surgery she underwent the year before led to the spread of endometrial stromal sarcoma, a rare type of uterine cancer. The operation was aided by a Storz Rotocut Morcellator, which the plaintiff claims to have upstaged a previously undiagnosed sarcoma that was in her uterus and later spread throughout her abdominal cavity; reducing her life-expectancy and diminishing her overall quality of life. This uterine sarcoma lawsuit names the manufacturer of this device, which was employed to cut, shred and remove uterine fibroids from her uterus, as defendant. Also in May, a claim filed in the U.S. District Court, Western District of New York included similar allegations that use of a power morcellator may lead to the spread of uterine sarcoma and other cancers.

Power Morcellator Lawsuits Follow FDA Alert in April

Over the past couple months, power morcellator concerns have continued to mount. The U.S. Food and Drug Administration (FDA) issued a public health alert on April 17th that discouraged doctors from using the devices after they were suggested to promote the spread of undetected uterine cancers. Among other things, the FDA warning estimated that 1 in 350 women who undergo fibroid removal surgeries may suffer from undiagnosed cancers.

The FDA plans to hold a meeting of its Obstetrics and Gynecological Medical Device Advisory later in the summer to investigate the possible dangers of uterine morcellation. Following the federal agency warning, Johnson & Johnson’s Ethicon unit stopped selling its Gynecare Morcellex Sigma Tissue Morcellator System and Gynecare X-Tract Tissue Morcellator pending further FDA investigation.

Other organizations have also begun to question the safety of morcellator-aided procedures. A report published by the American College of Obstetricians and Gynecologists (ACOG) on May 9th urges doctors to adequately relay the benefits and potential risks of this surgery to patients, and to provide them with alternative solutions.

Did You Undergo a Morcellator-Aided Hysterectomy or Fibroid Removal Surgery? Call Us Now.

Contact our Firm today to learn more about the alleged association between power morcellators and the risk for uterine sarcomas and other cancers. Call us now at (877) 779-1414.

Published May 19, 2014 by